Y1070_SIRV1
ID Y1070_SIRV1 Reviewed; 1070 AA.
AC Q8QL26; Q5TJ89;
DT 01-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT 01-JUN-2002, sequence version 1.
DT 23-FEB-2022, entry version 43.
DE RecName: Full=Uncharacterized protein 1070;
GN ORFNames=1070;
OS Sulfolobus islandicus rod-shaped virus 1 (SIRV-1) (Sulfolobus virus
OS SIRV-1).
OC Viruses; Adnaviria; Zilligvirae; Taleaviricota; Tokiviricetes;
OC Ligamenvirales; Rudiviridae; Icerudivirus; Icerudivirus SIRV1.
OX NCBI_TaxID=157898;
OH NCBI_TaxID=43080; Sulfolobus islandicus.
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=Isolate variant VIII;
RX PubMed=11878892; DOI=10.1006/viro.2001.1190;
RA Peng X., Blum H., She Q., Mallok S., Bruegger K., Garrett R.A., Zillig W.,
RA Prangishvili D.;
RT "Sequences and replication of genomes of the archaeal rudiviruses SIRV1 and
RT SIRV2: relationships to the archaeal lipothrixvirus SIFV and some eukaryal
RT viruses.";
RL Virology 291:226-234(2001).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=Isolate variant XX;
RX PubMed=15469509; DOI=10.1111/j.1365-2958.2004.04287.x;
RA Peng X., Kessler A., Phan H., Garrett R.A., Prangishvili D.;
RT "Multiple variants of the archaeal DNA rudivirus SIRV1 in a single host and
RT a novel mechanism of genomic variation.";
RL Mol. Microbiol. 54:366-375(2004).
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AJ414696; CAC93985.1; -; Genomic_DNA.
DR EMBL; AJ748296; CAG38849.1; -; Genomic_DNA.
DR RefSeq; NP_666618.1; NC_004087.1.
DR PRIDE; Q8QL26; -.
DR GeneID; 951385; -.
DR KEGG; vg:951385; -.
DR Proteomes; UP000002270; Genome.
DR Proteomes; UP000223181; Genome.
DR InterPro; IPR015940; UBA.
DR PROSITE; PS50030; UBA; 1.
PE 4: Predicted;
KW Reference proteome.
FT CHAIN 1..1070
FT /note="Uncharacterized protein 1070"
FT /id="PRO_0000342306"
FT DOMAIN 477..523
FT /note="UBA"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00212"
FT VARIANT 106
FT /note="I -> V (in strain: Isolate variant XX)"
FT VARIANT 165
FT /note="S -> N (in strain: Isolate variant XX)"
FT VARIANT 240
FT /note="E -> Q (in strain: Isolate variant XX)"
FT VARIANT 274
FT /note="Q -> N (in strain: Isolate variant XX)"
FT VARIANT 293
FT /note="R -> K (in strain: Isolate variant XX)"
FT VARIANT 303
FT /note="A -> E (in strain: Isolate variant XX)"
FT VARIANT 318..320
FT /note="VPK -> APR (in strain: Isolate variant XX)"
FT VARIANT 334..336
FT /note="TGS -> LGA (in strain: Isolate variant XX)"
FT VARIANT 355
FT /note="I -> L (in strain: Isolate variant XX)"
FT VARIANT 371
FT /note="L -> I (in strain: Isolate variant XX)"
FT VARIANT 388
FT /note="Q -> E (in strain: Isolate variant XX)"
FT VARIANT 392
FT /note="E -> Q (in strain: Isolate variant XX)"
FT VARIANT 396
FT /note="S -> G (in strain: Isolate variant XX)"
FT VARIANT 439
FT /note="K -> R (in strain: Isolate variant XX)"
FT VARIANT 449
FT /note="N -> E (in strain: Isolate variant XX)"
FT VARIANT 457
FT /note="D -> E (in strain: Isolate variant XX)"
FT VARIANT 479
FT /note="D -> Y (in strain: Isolate variant XX)"
FT VARIANT 493
FT /note="K -> R (in strain: Isolate variant XX)"
FT VARIANT 498
FT /note="N -> D (in strain: Isolate variant XX)"
FT VARIANT 552
FT /note="K -> N (in strain: Isolate variant XX)"
FT VARIANT 557
FT /note="L -> I (in strain: Isolate variant XX)"
FT VARIANT 562
FT /note="A -> V (in strain: Isolate variant XX)"
FT VARIANT 573..575
FT /note="VEQ -> IEP (in strain: Isolate variant XX)"
FT VARIANT 582
FT /note="T -> S (in strain: Isolate variant XX)"
FT VARIANT 628
FT /note="F -> L (in strain: Isolate variant XX)"
FT VARIANT 645
FT /note="V -> I (in strain: Isolate variant XX)"
FT VARIANT 676
FT /note="H -> Q (in strain: Isolate variant XX)"
FT VARIANT 680..682
FT /note="LET -> TES (in strain: Isolate variant XX)"
FT VARIANT 699
FT /note="E -> G (in strain: Isolate variant XX)"
FT VARIANT 702
FT /note="I -> V (in strain: Isolate variant XX)"
FT VARIANT 715
FT /note="F -> L (in strain: Isolate variant XX)"
FT VARIANT 725
FT /note="V -> I (in strain: Isolate variant XX)"
FT VARIANT 729
FT /note="V -> L (in strain: Isolate variant XX)"
FT VARIANT 745
FT /note="K -> R (in strain: Isolate variant XX)"
FT VARIANT 749
FT /note="D -> E (in strain: Isolate variant XX)"
FT VARIANT 780..781
FT /note="TD -> DN (in strain: Isolate variant XX)"
FT VARIANT 810
FT /note="V -> I (in strain: Isolate variant XX)"
FT VARIANT 830
FT /note="I -> V (in strain: Isolate variant XX)"
FT VARIANT 837
FT /note="S -> P (in strain: Isolate variant XX)"
FT VARIANT 840
FT /note="R -> K (in strain: Isolate variant XX)"
FT VARIANT 849..854
FT /note="IKILLD -> VKALLE (in strain: Isolate variant XX)"
FT VARIANT 868
FT /note="H -> Y (in strain: Isolate variant XX)"
FT VARIANT 884
FT /note="L -> P (in strain: Isolate variant XX)"
FT VARIANT 903..904
FT /note="IN -> TS (in strain: Isolate variant XX)"
FT VARIANT 911
FT /note="V -> I (in strain: Isolate variant XX)"
FT VARIANT 924
FT /note="T -> N (in strain: Isolate variant XX)"
FT VARIANT 937
FT /note="N -> S (in strain: Isolate variant XX)"
FT VARIANT 947
FT /note="A -> S (in strain: Isolate variant XX)"
FT VARIANT 952
FT /note="I -> M (in strain: Isolate variant XX)"
FT VARIANT 963
FT /note="L -> T (in strain: Isolate variant XX)"
FT VARIANT 1032
FT /note="K -> R (in strain: Isolate variant XX)"
FT VARIANT 1038
FT /note="G -> N (in strain: Isolate variant XX)"
FT VARIANT 1061
FT /note="I -> L (in strain: Isolate variant XX)"
SQ SEQUENCE 1070 AA; 123572 MW; E462310FD5DB6432 CRC64;
MFIILKRNIL INMSFLLNLG ELGTFFADEI ENLENFTNWI SSDFINFINA IVNDIKNIAS
FLGQAISDIP TFMVNIATNF LTILQNFVQT AISTIQGFVS WFEQQIVGAF EFLSSIASDF
INSAYSFFQN VANVFAQIIS GVISDFLNFF GANMKHISNA ISQLSQFLSP FIAPITIGKF
LPVIVDKLAE ILPEIEIDLA PVGLGGKIPI KFGEIIKAFA ETSVDFLNEI RTELATTLKE
FIKEPFISDF KISAREIFNE IGLGDLPFAD PPFQLIGRWV AVRSFDEVKD HLRETILLTG
YPAWFTNAYL ESPVNDFVPK NPLFRPVGIR DLITGSQYGI LNISDLEKYA YNNLITPKTA
KLMYQNQTAR LLQRAVEQGI RQFVITPQKA YEEIISNINL TGKELFLKTF TLEYEYAVQR
IVRQFLRSLL SRALSNFGKP YLDFKYLDNT IAKLFKDLGY PEEVRTVFDT MITQSQLIDT
NQLLLRQLQQ IVKLGIFNEK KIKEELKANK FNEQVALQIL ESELQFAQLQ NTLKEYQFKL
KSFLISPKDV EKDLKHLGFD SAIISALIYE NQVEQLIKFQ LTNIESLAKK GYLSLDEIKK
QFKAIGIIKE YEDAFINFIN QELQISAFLT ILKSQLRQFQ IDPKVAEAEL KKLNINEYLS
NQIIQEEYNI NIAKLHLSVL ETIAKTLYYD QQQLSGELEK IIKDKTALEL YIKKFYYEYI
YPKIVNYHVQ LARHGILSDI SKLPKEVIDY EIKPALLTYQ TTLEIEYIKE SLKDLEIKPT
DAINELEKLG MQKDIAQLIV NTYIPTFYNV HTIIQNIIEG QLYKVGKVPI NLGNAESELR
KLGIPDSQIK ILLDQYSTTF GLDIWRKHLP SISIIENAIK YNYLDQKLIE YSFIPSELLN
LYINYYQHLL VGQEVQSFKS EYITALIYNY QNLQLENLLK QYGINEALLS VIKLFAQVRK
IVLGLQELYL TPTKALSISE YVSNPQQLLQ KVFTEFQIPQ ELQNTYFEYA RNRRVSRYVN
EIITTINLLF EKHKIDLGTA QSYLQQLKKY GLTDEEIQLI ILNWQLRSAY
